Ethnic background is a determinant of average warfarin dose required to maintain the INR between 3.0 and 4.5

被引:9
作者
Blann, A [1 ]
Bareford, D [1 ]
机构
[1] City Hosp, Dept Haematol, Birmingham B18 7QH, W Midlands, England
关键词
D O I
10.1111/j.1538-7933.2003.00620.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:525 / 526
页数:2
相关论文
共 12 条
[1]   Racial background is a determinant of average warfarin dose required to maintain the INR between 2•0 and 3•0 [J].
Blann, A ;
Hewitt, J ;
Siddiqui, F ;
Bareford, D .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 107 (01) :207-209
[2]   Cytochrome P450 polymorphisms are associated with reduced warfarin dose [J].
Freeman, BD ;
Zehnbauer, BA ;
McGrath, S ;
Borecki, I ;
Buchman, TG .
SURGERY, 2000, 128 (02) :281-285
[3]  
Haemostasis and Thrombosis Task Force, 1998, BRIT J HAEMATOL, V101, P374
[4]   FACTORS AFFECTING THE MAINTENANCE DOSE OF WARFARIN [J].
JAMES, AH ;
BRITT, RP ;
RASKINO, CL ;
THOMPSON, SG .
JOURNAL OF CLINICAL PATHOLOGY, 1992, 45 (08) :704-706
[5]   Genetic polymorphism in exon 4 of cytochrome P450CYP2C9 may be associated with warfarin sensitivity in Chinese patients [J].
Leung, AYH ;
Chow, HCH ;
Kwong, YL ;
Lie, AKW ;
Fung, ATK ;
Chow, WH ;
Yip, ASB ;
Liang, R .
BLOOD, 2001, 98 (08) :2584-2587
[6]   Vitamin K intake and sensitivity to warfarin in patients consuming regular diets [J].
Lubetsky, A ;
Dekel-Stern, E ;
Chetrit, A ;
Lubin, F ;
Halkin, H .
THROMBOSIS AND HAEMOSTASIS, 1999, 81 (03) :396-399
[7]   CYP2C9 exon 4 mutations and warfarin dose phenotype in Asians [J].
Rettie, AE ;
Tai, GY ;
Veenstra, DL ;
Farin, FM ;
Srinouanprachan, S ;
Lin, YS ;
Thummel, KE ;
Hines, RN .
BLOOD, 2003, 101 (07) :2896-2897
[8]   Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearance [J].
Scordo, MG ;
Pengo, V ;
Spina, E ;
Dahl, ML ;
Gusella, M ;
Padrini, R .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (06) :702-710
[9]   ARE INDO-ORIGIN PEOPLE ESPECIALLY SUSCEPTIBLE TO CORONARY-ARTERY DISEASE [J].
SHAUKAT, N ;
DEBONO, DP .
POSTGRADUATE MEDICAL JOURNAL, 1994, 70 (823) :315-318
[10]   Population differences in S-warfarin metabolism between CYP2C9 genotype-matched Caucasian and Japanese patients [J].
Takahashi, H ;
Wilkinson, GR ;
Caraco, Y ;
Muszkat, M ;
Kim, RB ;
Kashima, T ;
Kimura, S ;
Echizen, H .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (03) :253-263